CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,984,216 | -27.4% | 356,809 | -2.2% | 0.01% | -30.0% |
Q2 2023 | $49,590,368 | +11.6% | 364,930 | -14.7% | 0.01% | +11.1% |
Q1 2023 | $44,435,064 | +33.6% | 427,836 | +14.0% | 0.01% | +28.6% |
Q4 2022 | $33,270,766 | -17.9% | 375,347 | -25.7% | 0.01% | -22.2% |
Q3 2022 | $40,513,000 | -14.3% | 505,340 | +2.3% | 0.01% | -18.2% |
Q2 2022 | $47,298,000 | -44.8% | 493,919 | -14.3% | 0.01% | -38.9% |
Q1 2022 | $85,619,000 | -1.1% | 576,366 | -5.6% | 0.02% | +5.9% |
Q4 2021 | $86,534,000 | +23.7% | 610,421 | +14.2% | 0.02% | +13.3% |
Q3 2021 | $69,928,000 | +7.0% | 534,488 | +12.4% | 0.02% | 0.0% |
Q2 2021 | $65,356,000 | -9.8% | 475,560 | -14.3% | 0.02% | -16.7% |
Q1 2021 | $72,450,000 | +14.3% | 554,789 | -2.0% | 0.02% | +12.5% |
Q4 2020 | $63,412,000 | +54.5% | 566,174 | +8.5% | 0.02% | +33.3% |
Q3 2020 | $41,038,000 | +0.2% | 521,655 | -8.3% | 0.01% | 0.0% |
Q2 2020 | $40,970,000 | +35.8% | 569,111 | +8.0% | 0.01% | +9.1% |
Q1 2020 | $30,169,000 | -46.9% | 526,799 | +3.6% | 0.01% | -21.4% |
Q4 2019 | $56,861,000 | +12.1% | 508,463 | -3.6% | 0.01% | -6.7% |
Q3 2019 | $50,735,000 | -9.4% | 527,671 | -19.3% | 0.02% | -6.2% |
Q2 2019 | $55,985,000 | -17.0% | 654,253 | -19.3% | 0.02% | -20.0% |
Q1 2019 | $67,449,000 | +28.2% | 810,876 | -1.1% | 0.02% | +17.6% |
Q4 2018 | $52,622,000 | -19.7% | 819,651 | -0.9% | 0.02% | 0.0% |
Q3 2018 | $65,504,000 | +12.6% | 826,860 | +4.0% | 0.02% | +6.2% |
Q2 2018 | $58,182,000 | +3.6% | 794,833 | -10.4% | 0.02% | +14.3% |
Q1 2018 | $56,168,000 | +3.2% | 886,916 | -16.9% | 0.01% | +7.7% |
Q4 2017 | $54,401,000 | +3.1% | 1,067,319 | +6.1% | 0.01% | 0.0% |
Q3 2017 | $52,769,000 | +6.0% | 1,005,702 | +2.9% | 0.01% | 0.0% |
Q2 2017 | $49,797,000 | +11.3% | 977,564 | -2.9% | 0.01% | +8.3% |
Q1 2017 | $44,728,000 | -3.1% | 1,007,160 | -3.6% | 0.01% | -7.7% |
Q4 2016 | $46,156,000 | +19.8% | 1,044,978 | +8.7% | 0.01% | +8.3% |
Q3 2016 | $38,526,000 | -16.6% | 961,701 | -0.6% | 0.01% | -20.0% |
Q2 2016 | $46,197,000 | +11.2% | 967,883 | -2.3% | 0.02% | +7.1% |
Q1 2016 | $41,546,000 | +94.0% | 990,609 | +103.8% | 0.01% | +100.0% |
Q4 2015 | $21,416,000 | +2225.3% | 486,186 | +2420.3% | 0.01% | – |
Q3 2015 | $921,000 | +138.6% | 19,291 | +191.1% | 0.00% | – |
Q2 2015 | $386,000 | -81.7% | 6,627 | -84.2% | 0.00% | -100.0% |
Q1 2015 | $2,112,000 | +604.0% | 41,832 | +527.7% | 0.00% | – |
Q4 2014 | $300,000 | -83.9% | 6,664 | -86.8% | 0.00% | -100.0% |
Q3 2014 | $1,863,000 | -36.5% | 50,579 | -23.8% | 0.00% | 0.0% |
Q2 2014 | $2,932,000 | +603.1% | 66,399 | +591.9% | 0.00% | – |
Q1 2014 | $417,000 | -83.4% | 9,597 | -83.8% | 0.00% | -100.0% |
Q4 2013 | $2,511,000 | +93.8% | 59,081 | +54.8% | 0.00% | – |
Q3 2013 | $1,296,000 | -16.7% | 38,167 | -23.3% | 0.00% | -100.0% |
Q2 2013 | $1,555,000 | -59.1% | 49,789 | -63.4% | 0.00% | -50.0% |
Q4 2012 | $3,804,000 | +24.8% | 136,116 | +27.2% | 0.00% | +100.0% |
Q3 2012 | $3,049,000 | +61.3% | 106,992 | +56.6% | 0.00% | 0.0% |
Q2 2012 | $1,890,000 | +230.4% | 68,321 | +257.0% | 0.00% | – |
Q1 2012 | $572,000 | – | 19,136 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |